title: Methods for diagnosis of bile acid malabsorption in clinical practice.
abstract: Altered concentrations of bile acid (BA) in the colon can cause diarrhea or constipation. More than 25% of patients with irritable bowel syndrome with diarrhea or chronic diarrhea in Western countries have BA malabsorption (BAM). As BAM is increasingly recognized, proper diagnostic methods are needed to help direct the most effective course of treatment for the chronic bowel dysfunction. We review the methodologies, advantages, and disadvantages of tools that directly measure BAM: the (14)C-glycocholate breath and stool test, the (75)selenium homotaurocholic acid test (SeHCAT), and measurements of 7 α-hydroxy-4-cholesten-3-one (C4) and fecal BAs. The (14)C-glycocholate test is laborious and no longer widely used. The (75)SeHCAT has been validated but is not available in the United States. Measurement of serum C4 is a simple and accurate method that can be used for most patients but requires further clinical validation. Assays to quantify fecal BA (total and individual levels) are technically cumbersome and not widely available. Regrettably, none of these tests are routinely available in the United States; assessment of the therapeutic effects of a BA binder is used as a surrogate for diagnosis of BAM. Recent data indicate the advantages to studying fecal excretion of individual BAs and their role in BAM; these could support the use of the fecal BA assay, compared with other tests. Measurement of fecal BA levels could become a routine addition to the measurement of fecal fat in patients with unexplained diarrhea. Availability ultimately determines whether the C4, SeHCAT, or fecal BA test is used; more widespread availability of such tests would enhance clinical management of these patients.
authors: Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, Minnesota.
authors: Priya
authors: P
authors: Vijayvargiya
authors: Michael
authors: M
authors: Camilleri
authors: Andrea
authors: A
authors: Shin
authors: Amy
authors: A
authors: Saenger
mesh_terms: D001647:Bile Acids and Salts / Q000032:analysis*; D005243:Feces / Q000737:chemistry*; D005260:Female; D005772:Gastrointestinal Transit; D006801:Humans; D007422:Intestines / Q000503:physiopathology*; D043183:Irritable Bowel Syndrome / Q000503:physiopathology*; D008297:Male
chemical_list: D001647:Bile Acids and Salts
keywords: (75)SeHCAT; (75)selenium homotaurocholic acid test; 7 α-hydroxy-4-cholesten-3-one; ASBT; BA; BAM; C4; CA; CDCA; CYP7A1; DCA; Diarrhea; Fecal; GC-MS; Glycocholate; HPLC; IBAT; IBS; LCA; MS; NADH; Na(+)-dependent bile salt transporter; SeHCAT; bile acid; bile acid malabsorption; chenodeoxycholic acid; cholesterol 7α hydroxylase; cholic acid; deoxycholic acid; gas chromatography–mass spectrometry; high-performance liquid chromatography; ileal BA transporter; irritable bowel syndrome; lithocholic acid; mass spectrometry; reduced nicotinamide adenine dinucleotide
references: Gastroenterology. 2010 Nov;139(5):1549-58, 1558.e1
references: 20691689
references: PLoS One. 2009 Aug 31;4(8):e6843
references: 19718444
references: Aliment Pharmacol Ther. 2009 Oct;30(7):707-17
references: 19570102
references: Lancet. 1971 Sep 18;2(7725):621-5
references: 4105944
references: Gut. 1982 Oct;23(10):862-5
references: 7117906
references: J Lipid Res. 2010 Jan;51(1):23-41
references: 20008121
references: Dig Dis Sci. 1999 Jan;44(1):14-9
references: 9952217
references: Gastroenterology. 1986 Jul;91(1):1-9
references: 3710057
references: Eur J Cancer Prev. 1991 Oct;1 Suppl 2:29-33
references: 1842729
references: Scand J Gastroenterol. 2008;43(12):1483-8
references: 18788050
references: Gastroenterology. 2005 Nov;129(5):1445-53
references: 16285946
references: Nucl Med Commun. 2011 Oct;32(10):960-6
references: 21876407
references: Clin Chim Acta. 1987 Feb 15;162(3):257-75
references: 3568403
references: Am J Physiol Gastrointest Liver Physiol. 2002 Mar;282(3):G443-9
references: 11841994
references: Gut. 1987 Aug;28(8):970-5
references: 3666565
references: Neurogastroenterol Motil. 2009 Jul;21(7):734-e43
references: 19368662
references: Gastroenterology. 1988 Feb;94(2):494-502
references: 3335321
references: FEBS Lett. 1988 Nov 7;239(2):324-8
references: 3181435
references: Ann Chir Gynaecol. 1992;81(4):351-3
references: 1485786
references: J Lab Clin Med. 2003 Jun;141(6):411-8
references: 12819639
references: Clin Gastroenterol Hepatol. 2009 Nov;7(11):1189-94
references: 19426836
references: J Nucl Med. 1991 Jun;32(6):1219-24
references: 2045936
references: Gut. 1973 May;14(5):348-53
references: 4736774
references: Gastroenterology. 1967 Apr;52(4):752-7
references: 5337211
references: J Lab Clin Med. 1979 Nov;94(5):661-74
references: 501195
references: J Clin Invest. 1971 Aug;50(8):1569-77
references: 4938344
references: Annu Rev Med. 1967;18:333-76
references: 5337530
references: Gut. 1991 Sep;32(9):1004-6
references: 1916479
references: Gastroenterology. 1983 May;84(5 Pt 1):969-77
references: 6299874
references: J Clin Gastroenterol. 1986 Jun;8(3 Pt 1):258-62
references: 3090133
references: Toxicol Sci. 2009 Apr;108(2):225-46
references: 19131563
references: Gut. 1977 Sep;18(9):742-8
references: 414968
references: Ann Pharmacother. 2006 Dec;40(12):2155-63
references: 17148650
references: J Lipid Res. 2003 Apr;44(4):859-66
references: 12562858
references: Neurogastroenterol Motil. 2010 Mar;22(3):293-e82
references: 20025692
references: Gastroenterology. 1986 Sep;91(3):619-26
references: 3525315
references: Int J Antimicrob Agents. 2009 Jan;33(1):4-7
references: 18804351
references: Clin Gastroenterol Hepatol. 2012 Sep;10(9):1009-15.e3
references: 22610000
references: J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):598-606
references: 18955863